Concepedia

Reversal of hypercoagulability in patients with <scp>HCV</scp>‐related cirrhosis after treatment with direct‐acting antivirals

Francesco Paolo Russo, Alberto Zanetto, Elena Campello, Cristiana Bulato, Sarah Shalaby, Luca Spiezia, Sabrina Gavasso, E. Franceschet, Claudia Maria Radu, Marco Senzolo,

Liver International · 2018 · 48 citations · 24 references

DOIFull text

Open access

Abstract

DAAs therapy in HCV-related cirrhotic patients is associated with significant changes in thrombin generation suggesting a reversal of hypercoagulability particularly in Child's A patients.

References

24

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

Journal of Hepatology · 2015 · 1.8K citations

EASL Recommendations on Treatment of Hepatitis C 2015

Journal of Hepatology · 2015 · 1.2K citations

, , +4

EASL Recommendations on Treatment of Hepatitis C 2016

Journal of Hepatology · 2016 · 976 citations

, , +4

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡

Armando Tripodi, Francesco Salerno, Veena Chantarangkul et al. · Hepatology · 2005 · 674 citations

An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis

Armando Tripodi, Massimo Primignani, Veena Chantarangkul et al. · Gastroenterology · 2009 · 535 citations · Full text

, , +12